4.7 Article

Polymyxin dose tunes the evolutionary dynamics of resistance in multidrug-resistant Acinetobacter baumannii

Journal

CLINICAL MICROBIOLOGY AND INFECTION
Volume 28, Issue 7, Pages -

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.cmi.2022.02.043

Keywords

Acinetobacter baumannii; Antibiotic resistance; Evolutionary dynamics; Polymyxin; Whole-population sequencing

Funding

  1. National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R01 AI132154, AI132681]
  2. Monash University Platform Access Grant [PAG21-4032448399]
  3. Australian Research Council [FT170100441]
  4. NHMRC [APP1186140]
  5. Australian Research Council [FT170100441] Funding Source: Australian Research Council

Ask authors/readers for more resources

The concentration of polymyxin has a critical impact on the evolution of resistance in Acinetobacter baumannii. Below a certain threshold concentration, resistance may develop but is not fixed, while concentrations above this threshold lead to irreversible resistance.
Objectives: Evolutionary principles have informed the design of strategies that slow or prevent antibiotic resistance. However, how antibiotic treatment regimens shape the evolutionary dynamics of resistance mutations remains an open question. Here, we investigate varying concentrations of the last-resort polymyxins on the evolution of resistance in Acinetobacter baumannii. Methods: Polymyxin resistance was measured in 18 multidrug-resistant A. baumannii AB5075 populations treated over 14 days with concentrations of polymyxin B informed by human pharmacokinetics. Time-resolved whole-population sequencing was conducted to track the genetics and population dynamics of susceptible and resistant subpopulations. Results: A critical threshold concentration of polymyxin B (1 mg/L; i.e. 4 x MIC) was identified. Below this threshold concentration, low levels of resistance repeatedly evolved, but no mutations were fixed, and this resistance was reversed upon removal of the antibiotic. This contrasted with evolution at super-MIC levels (>= 4 x MIC) of polymyxin B, which drove the evolution of irreversible resistance, with higher levels of antibiotic correlating with greater rates of molecular evolution. Polymyxin-resistant subpopulations carried mutations in a variety of genes, most commonly pmrB, ompA, glmU/glmS, and wecB/wecC, which contributed to membrane remodelling and virulence in A. baumannii. Conclusions: Our results show that the strength of the selective pressure applied by polymyxin tunes the dynamics of genetic variants within the population, leading to different evolutionary outcomes for the degree, cost and reversibility of resistance. Our study highlights the critical role of integrating evolutionary findings into pharmacokinetics/pharmacodynamics to optimise antibiotic use in patients. (C) 2022 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available